Cost–Effectiveness of Using CYP2C19 Genotype to Guide Selection of Clopidogrel or Ticagrelor in Australia
Year: 2013
Type: article
Source: Pharmacogenomics
DOI: 10.2217/pgs.13.164
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2018431503
